Search by Drug Name or NDC
NDC 50991-0776-01 Alahist D 17.5; 10 mg/1; mg/1 Details
Alahist D 17.5; 10 mg/1; mg/1
Alahist D is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 50991-0776 |
|---|---|
| Product ID | 50991-776_ef311398-9775-2727-e053-2995a90a749d |
| Associated GPIs | 43993002690330 |
| GCN Sequence Number | 080939 |
| GCN Sequence Number Description | phenylephrine HCl/pheniramine TABLET 10-17.5 MG ORAL |
| HIC3 | Z2N |
| HIC3 Description | 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION |
| GCN | 47927 |
| HICL Sequence Number | 000442 |
| HICL Sequence Number Description | PHENYLEPHRINE HCL/PHENIRAMINE MALEATE |
| Brand/Generic | Brand |
| Proprietary Name | Alahist D |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pheniramine Maleate, Phenylephrine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 17.5; 10 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Poly Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50991-0776-01 (50991077601)
| NDC Package Code | 50991-776-01 |
|---|---|
| Billing NDC | 50991077601 |
| Package | 100 TABLET in 1 BOTTLE (50991-776-01) |
| Marketing Start Date | 2020-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |